Kura Oncology (KURA) SEC Filings & 10K Form

$19.00
+0.25 (+1.33%)
(As of 04/25/2024 ET)

Recent Kura Oncology SEC Filings

DateFilerForm TypeView
04/12/2024
3:26 PM
Kura Oncology (Filer)
Form DEF 14A
04/12/2024
3:26 PM
Kura Oncology (Filer)
Form DEFA14A
02/14/2024
11:15 PM
Kura Oncology (Filer)
Form EFFECT
02/14/2024
8:39 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/13/2024
4:23 PM
Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/12/2024
4:33 PM
Flynn James E (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
02/09/2024
4:21 PM
Kura Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/31/2024
4:30 PM
DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
6:08 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
01/23/2024
8:12 AM
Kura Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/04/2024
3:06 PM
DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Kura Oncology (Issuer)
Powl Brian T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:08 PM
DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:06 PM
Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
8:01 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:39 PM
Kura Oncology (Filer)
Form S-3ASR
09/21/2023
3:55 PM
Flynn James E (Filed by)
Kura Oncology (Subject)
Form SC 13G
08/03/2023
3:13 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:29 PM
Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:08 PM
Kura Oncology (Filer)
Form 424B5
06/12/2023
5:06 AM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
3:07 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KURA) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners